rylaze solution
jazz pharmaceuticals ireland limited - crisantaspase - solution - 10mg - crisantaspase 10mg
asparaginase pfi 10,000iu injection
asparaginase - injection - 10,000 iu - asparaginase
leunase
sanofi-aventis new zealand limited - asparaginase 10000 [iu] (derived from cultures of e.coli hap ex japan, expressed as 10,000ku) - powder for injection - 10,000ku - active: asparaginase 10000 [iu] (derived from cultures of e.coli hap ex japan, expressed as 10,000ku) - treatment of acute lymphoblastic leukaemia
erwinase
new zealand medical & scientific ltd - asparaginase 10000 [iu] - powder for injection - 10000 iu - active: asparaginase 10000 [iu] excipient: glucose monohydrate sodium chloride water for injection - erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. it may also be used in other neoplastic conditions where depletion of asparagines might be expected to have a useful effect. patients receiving treatment with l-asparaginase from escherichia coli, and who develop hypersensitivity to that enzyme may be able to continue treatment with erwinase as the enzymes are immunologically distinct.
asparaginase medac
medac gmbh - l-asparaginase - powder lyophilized for solution for injection - 10000u
asparaginase medac
medac gmbh - l-asparaginase - powder lyophilized for solution for injection - 5000u
asparaginase 10000 e medac
asparaginase 5000 e medac
erwinase 10 000 e./durchstechflasche pulver zur herstellung einer injektions-/infusionslösung